Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.
Frequently asked questions
What sector does Sernova Biotherapeutics Inc (PSH0) operate in?
Sernova Biotherapeutics Inc belongs to the Other sector and operates in the Biotechnology industry.
What is Sernova Biotherapeutics Inc (PSH0) current stock price?
As of the latest data, Sernova Biotherapeutics Inc stock price is €0.05, with a previous close of €0.07. Sernova Biotherapeutics Inc lost -€0.02 in the last trading session, representing a -23.45% loss.
What is Sernova Biotherapeutics Inc (PSH0) current market capitalization?
Sernova Biotherapeutics Inc market cap is approximately 20.47 million.
What is Sernova Biotherapeutics Inc (PSH0) Earnings Per Share (EPS)?
The trailing EPS is -€0.07.
Does Sernova Biotherapeutics Inc (PSH0) pay dividends?
No. Sernova Biotherapeutics Inc does not pay a dividend.
When is Sernova Biotherapeutics Inc (PSH0) next earnings report?
Sernova Biotherapeutics Inc is expected to release its next earnings report on October 31, 2026.
What is Sernova Biotherapeutics Inc (PSH0) beta (volatility) score?
Sernova Biotherapeutics Inc has a beta of 0.641, indicating lower volatility than the overall market.